Center-Authored Papers

Filters: Author is Baker, Laurence H  [Clear All Filters]
Journal Article
Greenberg RE, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R, Lazcano-Ponce EC et al..  2011.  14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.. Lancet. 378(9790):507-14. Abstract
Bennette CS, Veenstra DL, Basu A, Baker LH, Ramsey SD, Carlson JJ.  2016.  Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.. Medical decision making : an international journal of the Society for Medical Decision Making. Abstract
Lippman SM, Klein EA, Goodman PJ, Lucia SM, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano MJ, Hartline JA et al..  2009.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 301(1):39-51. Abstract
Porras C, Nodora J, Sexton R, Ferreccio C, Jimenez S, Dominguez RL, Cook P, Anderson G, Morgan DR, Baker LH et al..  2013.  Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701).. Cancer causes & control : CCC. 24(2):209-15. Abstract
Deverka PA, Lavallee DC, Desai PJ, Armstrong J, Gorman M, Hole-Curry L, O'Leary J, Ruffner B, Watkins J, Veenstra DL et al..  2012.  Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process.. Journal of comparative effectiveness research. 1(4):359-370. Abstract
Ramsey SD, Veenstra D, Tunis SR, Garrison L, Crowley JJ, Baker LH.  2011.  How comparative effectiveness research can help advance 'personalized medicine' in cancer treatment.. Health affairs (Project Hope). 30(12):2259-68. Abstract
Redman MW, Goldman BH, LeBlanc M, Schott A, Baker LH.  2013.  Modeling the relationship between progression-free survival and overall survival: the phase II/III trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(10):2646-56. Abstract
Goodman PJ, Hartline JA, Tangen CM, Crowley JJ, Minasian LM, Klein EA, Cook ED, Darke AK, Arnold KB, Anderson K et al..  2012.  Moving a randomized clinical trial into an observational cohort.. Clinical trials (London, England). Abstract
Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond KA, Bramwell VHC, Baker LH, Maki RG et al..  2008.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(4):626-32. Abstract
Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martínez E, Greenberg RE, Bravo LE, Dominguez RL, Ferreccio C, Lazcano-Ponce EC et al..  2013.  Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.. JAMA : the journal of the American Medical Association. 309(6):578-86. Abstract
Hoban CJ, Franklin W, Kopecky KJ, Baker LH.  2011.  SWOG Cooperative Group Biorepository Resource: Access for Scientific Research Studies.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(16):5239-46. Abstract
Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford DE.  2008.  Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.. Cancer. 112(10):2181-7. Abstract
Klein EA, Thompson IM, Tangen CM, Crowley J, Lucia SM, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano MJ et al..  2011.  Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 306(14):1549-56. Abstract